It is less than 90 days to the end of FY 2009. The hype on Relenza has so far fail to arrest the momentous downward trend in sales despite one of the most severe Northern hemisphere flu season.
There were no announced sales to the pandemic stockpile market since the UK sales. Peter Cook was very coy on the details of the UK timeline which could take up to 2 or 3 years.
In the last sale report, it took Peter Cook weeks to correct the wrong Relenza sales figure he (Peter Cook) announced to the ASX. Surprise, surprise- Peter Cook blamed GSK for the error notwithstanding that the correct Relenza sales report was public information on GSK website.
GSK is due to release their 1Q Relenza sales on 22 April 2009. What will it be?
BTA Price at posting:
60.0¢ Sentiment: ST Sell Disclosure: Not Held
